プロの翻訳者、企業、ウェブページから自由に利用できる翻訳レポジトリまで。
preparatomtale
summary of product characteristics
最終更新: 2017-04-26
使用頻度: 1
品質:
preparatomtale (smpc)
summary of product characteristics (smpc)
最終更新: 2017-04-26
使用頻度: 1
品質:
preparatomtale (spc).
summary of product characteristics.
最終更新: 2017-04-26
使用頻度: 1
品質:
produktinformasjon (preparatomtale)
product information (spc)
最終更新: 2017-04-26
使用頻度: 1
品質:
preparatomtale og pakningsvedlegg
summary of product characteristics and package leaflet
最終更新: 2017-04-26
使用頻度: 3
品質:
preparatomtale for kobicistat).
(see cobicistat smpc).
最終更新: 2017-04-26
使用頻度: 1
品質:
se preparatomtale (spc) for
refer to the summary of
最終更新: 2017-04-26
使用頻度: 1
品質:
se preparatomtale for boceprevir.
refer to the smpc for boceprevir.
最終更新: 2017-04-26
使用頻度: 1
品質:
preparatomtale (smpc) og pakingsvedlegg
summary of product characteristics (smpc) and package leaflet
最終更新: 2017-04-26
使用頻度: 1
品質:
preparatomtale, pakningsvedlegg og merking
summary of product characteristics, package leaflet and labelling
最終更新: 2017-04-26
使用頻度: 1
品質:
preparatomtale og pakningsvedlegg for daliresp
summary of product characteristics and patient information leaflet for daliresp
最終更新: 2017-04-26
使用頻度: 1
品質:
preparatomtale (smpc), pakningsvedlegg og merking
summary of product characteristics (smpc) and package leaflet and labelling
最終更新: 2017-04-26
使用頻度: 1
品質:
preparatomtale (spc) og pakningsvedlegg og merking
summary of product characteristics (spc) and package leaflet and labelling
最終更新: 2017-04-26
使用頻度: 1
品質:
for dosejustering av trastuzumab, se egen preparatomtale.
for trastuzumab dose modifications, see trastuzumab summary of product characteristics.
最終更新: 2017-04-26
使用頻度: 1
品質:
for dosejustering av cisplatin, se korresponderende preparatomtale.
for cisplatin dose adjustments, see the corresponding summary of product characteristics.
最終更新: 2017-04-26
使用頻度: 1
品質:
uventete bivirkninger i henhold til godkjent preparatomtale.
unexpected adrs according to the spc.
最終更新: 2017-04-26
使用頻度: 1
品質:
for ytterligere detaljer, se egen preparatomtale for trastuzumab.
for more details see summary of product characteristics of trastuzumab.
最終更新: 2017-04-26
使用頻度: 1
品質:
vedlegg: preparatomtale, rekonstitueringsveiledning for helsepersonell, infusjonsdagbok.
annex: smpc; healthcare professional reconstitution guide, infusion diary
最終更新: 2017-04-26
使用頻度: 1
品質:
for mer detaljerte instrukser, se preparatomtale eller pakningsvedlegg.
for more detailed instructions, please refer to the summary of product characteristics or the package leaflet.
最終更新: 2017-04-26
使用頻度: 1
品質:
for ytterligere informasjon vedrørende deksametason, se tilhørende preparatomtale.
for additional information concerning dexamethasone, see the corresponding summary of product characteristics.
最終更新: 2017-04-26
使用頻度: 1
品質: